Researchers modify hepatitus B virus for targeted drug delivery

Stanford researchers have redesigned the hepatitis B virus so that it is invisible to the immune system and can target certain cells without delivering an infectious payload. This report was published in the Proceedings of the National Academy of Sciences, and professor of chemical engineering and bioengineering James Swartz, who led the report, hopes his findings will advance targeted drug delivery.